Medications

Merck continuing study of cholesterol drug in new class

Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...

Immunology

Sublingual immunotherapy tablet safe in asthma patients

(HealthDay)—For individuals with asthma and allergic rhinitis with/without conjunctivitis (AR/C), treatment with a Timothy grass sublingual immunotherapy tablet (SLIT-tablet) seems safe, according to research published ...

Diseases, Conditions, Syndromes

EU medicines agency starts review of Merck oral COVID drug

The EU's medicines watchdog said on Monday it had started reviewing an oral COVID medication from the US pharmaceutical firm Merck, raising hopes for an easy-to-administer treatment to reduce serious or deadly cases.

Medications

Merck recalls cholesterol drug Liptruzet (Update)

(HealthDay)—Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock.

Medications

Merck: FDA won't OK its combo cholesterol drug now

(AP) -- Federal regulators have rejected Merck & Co.'s new combination cholesterol drug, which includes a generic version of the mega-blockbuster Lipitor - at least for now.

Medications

Merck seeks new OK for cancer drug, reorganization on track

Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer.

Medications

FDA OKs Cubist antibiotic for serious infections

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Medications

Bristol-Myers ends hepatitis C drug development

(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

Medical economics

German pharma Merck makes bid for US group Versum

German pharmaceutical group Merck KgaA said Wednesday it had offered to buy electronics industry supplier Versum Materials for 5.3 billion euros ($6 billion), its biggest purchase in four years.

page 5 from 14